Author:
Brock Inger,Ruhwald Morten,Lundgren Bettina,Westh Henrik,Mathiesen Lars R,Ravn Pernille
Abstract
Abstract
Background
Although tuberculosis (TB) is a minor problem in Denmark, severe and complicated cases occur in HIV positive. Since the new M. tuberculosis specific test for latent TB, the QuantiFERON-TB In-Tube test (QFT-IT) became available the patients in our clinic have been screened for the presence of latent TB using the QFT-IT test. We here report the results from the first patients screened.
Methods
On a routine basis the QFT-IT test was performed and the results from 590 HIV positive individuals consecutively tested are presented here. CD4 cell count and TB risk-factors were recorded from patient files.
Main findings
27/590(4.6%) of the individuals were QFT-IT test positive, indicating the presence of latent TB infection. Among QFT-IT positive patients, 78% had risk factors such as long-term residency in a TB high endemic area (OR:5.7), known TB exposure (OR:4.9) or previous TB disease (OR:4.9). The prevalence of latent TB in these groups were 13%, 16% and 19% respectively. There was a strong correlation between low CD4 T-cell count and a low mitogen response (P < 0.001;Spearman) and more patients with low CD4 cell count had indeterminate results.
Conclusion
We found an overall prevalence of latent TB infection of 4.6% among the HIV positive individuals and a much higher prevalence of latent infection among those with a history of exposure (16%) and long term residency in a high endemic country (13%). The QFT-IT test may indeed be a useful test for HIV positive individuals, but in severely immunocompromised, the test may be impaired by T-cell anergy.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. WHO: Global tuberculosis control- surveillance, planning, financing. WHO report 2005.
[http://www.who.int/tb/publications/global_report/2005/en/]
WHO/HTM/TB/2005 2005.
2. Horsburgh CR Jr: Priorities for the treatment of latent tuberculosis infection in the United States.
N Engl J Med
350(20):2060–7. 2004; May 13
3. Lawn SD, Bekker LG, Wood R: How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control.
AIDS 2005,19(11):1113–1124. July 22
4. American Thoracic Society: Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.
MMWR Recomm Rep 2000,49(RR-6):1–51.
5. Lein AD, von-Reyn CF, Ravn P, Horsburg CR, Alexander LN, Andersen P: Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium tuberculosis.
Clin Diagn Lab 1999, 6:606–609.
Cited by
175 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献